policy impact with FIPRA
François Meyer is a Special Advisor on Health Technology Assessment (HTA). François has held high-level positions at the French National Authority for Health (HAS) and brings extensive experience into the FIPRA team on HTA .
François joined the management team of HAS in 2005, leading the setup of the HTA Division across key areas like pharmaceuticals, medical devices, interventional and diagnostic procedures, and public health programs. He expanded HAS's role in economic analysis within France's HTA field. He then focused on international cooperation, serving on the HTAi Board for two terms, coordinating EUnetHTA activities, and representing HAS in projects including Post Launch Evidence Generation with HTA-EMA cooperation.
Before joining HAS, François held management roles at the French Medicines Agency (now ANSM). He was active at the EMA, serving on the Committee for Orphan Medicinal Products.
François holds an MD in Internal Medicine and Endocrinology from the University of Montpellier, practiced at teaching hospitals there for years, and later worked at a prominent pharmaceutical company.
EN - FR
Healthcare, Life sciences & wellbeing